Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS Provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full Nondiscrimination Statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

BMC’s Center of Excellence in Sickle Cell Disease serves more than 600 patients, from newborns to adults, annually. The center’s multidisciplinary team includes sickle cell disease specialists, as well as primary care, nurses, social workers, and departments across the hospital to ensure that patients get consistent and coordinated care. We are committed to providing patients with highly personalized care across childhood, teenage years, and adulthood so they can live as normal a life as possible. 

Leading Expertise

Largest sickle cell disease center

 in New England, serving over 600 adult and pediatric patients per year

Access to gene therapies

as the only hospital in New England that offers both FDA-approved gene therapies for sickle cell disease, Casgevy and Lyfegenia 

Unique transitional care programs

 to help patients navigate the transition of care from pediatrics to adulthood

Sickle Cell Disease - Adult Clinic

We’re home to the largest center for sickle cell disease in New England, with hematologists who specialize in treating adults with SCD.

Sickle Cell Disease - Pediatric Clinic

In BMC’s Pediatric Sickle Cell Program, our specialists provide comprehensive care for hundreds of pediatric patients and understand the specific needs of kids born with sickle ce…

Sickle Cell Disease - Transitional Care

BMC’s Transitional Care Clinic team, which includes both pediatric and adult sickle cell specialists, works closely with patients and their families during this time to help our y…
⁣"At BMC, I am able to ask questions and learn more," Ingrid says. "Advocating for yourself and your care is so important, especially for SCD."⁣ Ingrid Ortiz
Hear more from Ingrid
September is Sickle Cell Disease Awareness Month. Ingrid Ortiz, who was diagnosed with SCD when she was born. Instagram story.

Information You May Need

Education and Training

Sickle Cell Disease Advanced Fellowship

In 2022, BMC launched a one-year non-ACGME accredited fellowship in sickle cell disease to increase knowledge in the care of adults with sickle cell disease. This program, one of only two adult SCD fellowships in the US, was designed to increase the number of physicians who can care for adults living with SCD in the future.  

Hematology Research Track

Fellows who are interested in hematology research can join the four-year hematology research track. While the clinical training is equivalent to the hematology/oncology fellowship, this track involves two years dedicated to basic, translational, or clinical research related to hematology.

Research

Sickle Cell Disease Research Overview

BMC researchers are finding innovative new ways to treat and cure blood disorders. As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions.